Mauro Krampera
Overview
Explore the profile of Mauro Krampera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
6049
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farina M, Bernardi S, Malagola M, Re A, Galli E, Riva M, et al.
Bone Marrow Transplant
. 2025 Feb;
PMID: 39955412
No abstract available.
2.
Bonelli F, Moosavizadeh S, Fasolo E, Di Nella A, Barbaro V, Zorzi I, et al.
Ocul Surf
. 2025 Feb;
36:224-236.
PMID: 39914484
Purpose: To develop and characterize a reproducible human corneal epithelial wound-healing model using 1-heptanol, and to investigate the healing potential of Bone Marrow-derived Mesenchymal Stromal Cell small Extracellular Vesicles (MSC-sEV)...
3.
Stella F, Pennisi M, Chiappella A, Casadei B, Bramanti S, Ljevar S, et al.
Transplant Cell Ther
. 2025 Jan;
PMID: 39870308
Background: Anti-CD19 CAR T-cells have revolutionized outcomes in relapsed/refractory large B-cell lymphomas. Long-term follow-up underscored the role of hematological toxicity in nonrelapse mortality, largely driven by infections, leading to the...
4.
Le Blanc K, Dazzi F, English K, Farge D, Galipeau J, Horwitz E, et al.
Cytotherapy
. 2025 Jan;
PMID: 39864015
The December 2024 US Food and Drug Administration (FDA) approval of Mesoblast's Ryoncil (remestemcel-L-rknd)-allogeneic bone marrow mesenchymal stromal cell (MSC(M)) therapy-in pediatric acute steroid-refractory graft-versus-host-disease finally ended a long-lasting drought...
5.
Perutelli F, Boccellato E, Montalbano M, Catania G, Deodato M, Frustaci A, et al.
Br J Haematol
. 2025 Jan;
206(3):924-929.
PMID: 39777647
Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains an option for young and fit chronic lymphocytic leukaemia (CLL) patients with high-risk disease features. However, allotransplanted patients are generally excluded from clinical...
6.
Stella F, Chiappella A, Magni M, Bonifazi F, De Philippis C, Musso M, et al.
Br J Haematol
. 2024 Dec;
206(2):644-651.
PMID: 39710966
Brexucabtagene autoleucel (brexu-cel) has revolutionized the treatment of patients affected by mantle cell lymphomas. In this prospective, observational multicentre study, we evaluated 106 patients, with longitudinal brexu-cel kinetics in peripheral...
7.
Cairoli R, Gatti A, Grillo G, Stefanucci M, Di Camillo B, Fumagalli M, et al.
Am J Hematol
. 2024 Dec;
100(2):346-349.
PMID: 39659145
Samples from 34 adult patients newly diagnosed with core binding factor leukemia (CBFL) were collected both at the time of diagnosis and at relapse and were centrally analyzed. Eligible patients...
8.
Galasso M, Salaorni V, Moia R, Mozzo V, Lovato E, Cosentino C, et al.
Hematol Oncol
. 2024 Nov;
42(6):e70002.
PMID: 39540258
Chronic lymphocytic leukemia (CLL) is characterized by an extremely variable clinical course. Although several parameters have been shown to be associated with clinical outcomes in patients with CLL, there remains...
9.
Mosna F, Borlenghi E, Litzow M, Byrd J, Papayannidis C, Tecchio C, et al.
Haematologica
. 2024 Oct;
110(3):608-620.
PMID: 39385741
Acute myeloid leukemia (AML) is mainly a disease of the elderly: however, knowledge about the outcomes of treatment of core-binding factor (CBF) AML in an older population is limited. We...
10.
Caminati M, Carpagnano L, Alberti C, Amaddeo F, Bixio R, Caldart F, et al.
World Allergy Organ J
. 2024 Aug;
17(8):100928.
PMID: 39156600
Hypereosinophilic syndromes (HES) represent a group of rare dis-immune conditions characterized by blood hyper-eosinophilia and eosinophilic related burden. Especially the idiopathic subtype (I-HES) is particularly difficult to diagnose because of...